Skip to main content
. 2023 Feb 1;24(3):2738. doi: 10.3390/ijms24032738

Table 2.

Comparison of demographic data, oxidative stress, and embryo quality between Pre-MT and MT groups, and clinical outcomes.

Pre-MT Group MT Group p Value
Number of patients 33 33
Age 34.6 ± 3.7 36.4 ± 3.9 n.s.
Body mass index (BMI) 21.1 ± 3.2 21.2 ± 3.3 n.s.
Anti-Müllerian hormone (AMH) (ng/mL) 4.2 ± 4.8 1.8 ± 1.5 n.s.
Diacron-Reactive Oxygen Metabolites tests (d-ROM) (CARR U) 354.9 ± 66.1 321.1 ± 81.5 n.s.
Biological Antioxidant Potential (BAP) (μmol/L) 2222.5 ± 54.9 2270.3 ± 207.6 n.s.
Total oocyte No. 718 387
Average oocyte No. retrieved per patient 8.4 ± 4.4 11.4 ± 6.9 p < 0.05
Total fertilized oocytes No. 459 208
Average No. of fertilized oocytes per patient 5.2 ± 3.1 6.2 ± 3.5 p < 0.05
Average fertilization rate (%) 61.8 ± 19.9 59.3 ± 22.8 n.s.
Total No. of transferable embryos 163 119
Average transferable embryo rate per zygote (%) 33.2 ± 23.2 62.4 ± 22.3 p < 0.05
Average good-quality embryo rate per zygote (%) 6.9 ± 9.3 23.7 ± 24.4 p < 0.05
Average EQS of the transferable embryo on Day 3 1.1± 1.0 1.9 ± 0.9 p < 0.05
No. of embryos transferred 98 78
No. of embryo transfers 91 51
Clinical pregnancy rate per embryo transfer (%) 0 27.4 (14/51) p < 0.05
Live birth rate per embryo transfer (%) 0 21.5 (11/51) p < 0.05
No. of babies born 0 13
Miscarriage rate (%) ND 21.4 (3 /14)

There were no significant differences in demographic data and oxidative status between the Pre-MT and MT groups. The d-Rom value can be broken down as follows: {Pre-MT < 340 (CARR U) (57.1%), 341–400 (19%), 401–500 (19%), 500 (4.7%)}, {MT < 340 (CARR U) (69.5%), 341–400 (17.4%), 401–500 (8%), 500 (4.3%)}. The good-quality embryo rates, transferable embryo rates per zygote, and EQS significantly increased. The clinical pregnancy rates and live birth rates were improved after MT. EQS: Embryo Quality Scoring. p < 0.05 statistically significant.